Vivos is advancing its product line by securing patents via USPTO filings and gaining unprecedented 510K clearances for an alternative to CPAP technology.
3 reports, 1 independent
Updated Aug 14
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vivos is advancing its product line by securing patents via USPTO filings and gaining unprecedented 510K clearances for an alternative to CPAP technology.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Vivos acquired equity and patents from SOD Sciences on October 26, 2026.Sub-event
Vivos secures 510K clearances and patents for CPAP alternative.1 source
Keep exploring
The entities involved
- FDA
-
Vivos
California-based company, that provdes hardened underground shelters designed to withstand future disasters and life-extinction catastrophes
Nothing else this week.
-
United States Patent and Trademark Office
agency in the United States Department of Commerce
Nothing else this week.
Related events
- Providence Medical Technology, Inc. received 510(k) clearance from the FDA and plans to showcase its system at the Henry B. González Convention Center.
- Policymakers are considering ways to influence the drug market, including potential changes to patent rights and the FDA approval process.
- FDA granted 510(k) clearance for combined technologies for Solventum.